CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement

RegulatoryapprovedPositive

AI Analysis

Summary

CytoSorbents Corporation has regained compliance with Nasdaq's minimum bid price requirement, resolving a listing standard violation for the blood purification company.

Outcome Details

Regained compliance with Nasdaq Stock Market minimum bid price requirement

Importance:3/10

Sentiment:

0.60

compliancenasdaqregulatorystock price

Related Companies

$CTSO

Read the original article

Published by PR Newswire Biotech on September 23, 2026 11:00 AM

Read Original